04.08.20: Post Q2 Virtual Roadshow
Post Q2 Virtual RoadshowLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 3, 2020 Category: Pharmaceuticals Source Type: news
03.08.20: Bayer completes the sale of its Animal Health business unit to Elanco
Bayer completes the sale of its Animal Health business unit to Elancomehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - August 3, 2020 Category: Pharmaceuticals Source Type: news
04.08.20: Q2 2020 Investor Conference Call
Q2 2020 Investor Conference CallLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 21, 2020 Category: Pharmaceuticals Source Type: news
21.07.20: Start of Quiet Period
Start of Quiet PeriodLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 20, 2020 Category: Pharmaceuticals Source Type: news
16.07.20: Not intended for U.S. and UK Media
U.S. FDA grants priority review to New Drug Application for vericiguat to treat chronic heart failuremehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 16, 2020 Category: Pharmaceuticals Source Type: news
09.07.20: Not intended for U.S. and UK Media
Bayer's finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetesFinerenone significantly reduced the combined primary endpoint of chronic kidney disease progression, kidney failure or kidney death versus placebo when added to standard of care / Finerenone significantly reduced the combined key secondary endpoint of cardiovascular death or non-fatal cardiovascular events / Chronic kidney disease impacts 4 in 10 patients with type 2 diabetes and is a deadly condition that is underrecognized / Finerenone is the first investigational non-steroid...
Source: Bayer IR Newsfeed: Events - July 9, 2020 Category: Pharmaceuticals Source Type: news
08.07.20: Bayer remains committed to Roundup™ settlement
Bayer remains committed to Roundup™ settlementmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 8, 2020 Category: Pharmaceuticals Source Type: news
01.07.20: not for distribution in the united states of america, australia, canada, south africa or japan
Bayer issues new senior bonds with a volume of 6 billion eurosIssuance of four tranches with maturities between 4 and 12 years was substantially oversubscribedmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 2, 2020 Category: Pharmaceuticals Source Type: news
24.06.20: Bayer announces agreements to resolve major legacy Monsanto litigation
Bayer announces agreements to resolve major legacy Monsanto litigationCompany will make a total payment of $10.1 billion to $10.9 billion (?9.1 billion to ?9.8 billion) to resolve current and address potential future Roundup™ litigation / Company also resolves dicamba drift litigation for payment of up to $400 million and most PCB water litigation exposure for payment of approximately $820 million / Funding sourced from free cash flow and Animal Health divestment / Bayer is well positioned to deliver science-based solutions to meet global health, nutrition needsmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 25, 2020 Category: Pharmaceuticals Source Type: news
25.06.20: Investor Conference Call: Agreements to Resolve Major Legacy Monsanto Litigation
Investor Conference Call: Agreements to Resolve Major Legacy Monsanto LitigationLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 24, 2020 Category: Pharmaceuticals Source Type: news
19.06.20: Women empowerment in times of COVID-19
Bayer supports "The Challenge Initiative" of Johns Hopkins Bloomberg School of Public Health with 10 million USD"The Challenge Initiative" to scale up reproductive health for women and girls in urban poverty areas / Participating cities in East Africa, Francophone West Africa, Nigeria, and India / Integrate COVID-19 prevention and educationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 19, 2020 Category: Pharmaceuticals Source Type: news
17.06.20: Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19
Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19Through its new "Better Farms, Better Lives" initiative, Bayer will complement its current commitment to support smallholder farmers in key countries by donating seeds and crop protection inputs / The donations help boost food security by supporting up to two million smallholder farmers facing increased challenges as a result of the on-going COVID-19 pandemicmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 17, 2020 Category: Pharmaceuticals Source Type: news
15.06.20: Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fractionFINEARTS-HF is the first large-scale, long-term study to investigate the non-steroidal, selective mineralocorticoid receptor antagonist finerenone on morbidity and mortality outcomes in a heart failure patient populationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 16, 2020 Category: Pharmaceuticals Source Type: news
05.06.20: Not intended for U.S. and UK Media
Bayer submits vericiguat for marketing authorization in the EU and Japan for the treatment of chronic heart failureRegulatory submissions based on positive data from Phase III VICTORIA study recently published in the New England Journal of Medicine (1)mehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - June 5, 2020 Category: Pharmaceuticals Source Type: news
04.06.20: Deutsche Bank Virtual Access Berlin Conference 2020, Berlin, Germany
Deutsche Bank Virtual Access Berlin Conference 2020, Berlin, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 29, 2020 Category: Pharmaceuticals Source Type: news
